Jazz Pharmaceuticals plc
JAZZ
$229.63
$0.440.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 416.86% | 6.45% | 16.91% | -526.22% | -532.78% |
| Total Depreciation and Amortization | 10.07% | 6.38% | 7.88% | 6.73% | 0.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -177.76% | -55.76% | -291.54% | 3,516.77% | 12.30% |
| Change in Net Operating Assets | -104.20% | 9.00% | 595.98% | -1,120.31% | 410.28% |
| Cash from Operations | -5.03% | -9.05% | 19.03% | -73.18% | 60.84% |
| Capital Expenditure | -41.73% | -25.91% | -40.67% | -82.87% | -101.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 192.07% | -113.11% | -239.02% | 192.00% | 41.47% |
| Cash from Investing | 172.84% | -92.54% | -253.12% | -149.34% | 37.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.97% | 0.00% | 98.67% | 0.00% | -9,678.06% |
| Issuance of Common Stock | 186.09% | 826.34% | 4,211.76% | -4.05% | 2,227.94% |
| Repurchase of Common Stock | -54.17% | 50.16% | 97.49% | 22.53% | -36.32% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 90.35% | 1,011.66% | -104.39% | 22.70% | -1,338.50% |
| Foreign Exchange rate Adjustments | -123.53% | 101.44% | -93.39% | 709.22% | 200.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 182.11% | -66.19% | -84.21% | -667.35% | -775.65% |